-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
There is little information on whether changes in metabolic syndrome (MetS) status affect the risk of new-onset atrial fibrillation (AF)
Metabolic syndrome
Recently, the heart blood vessels published a research article on the disease areas authoritative magazine JAHA, researchers aimed to use the data to evaluate changes in the state of MetS and MetS components from all observational cohort of whether the impact of AF risk
Heart blood vessels
The study identified a total of 7,565,531 adults without AF (average age 47 ± 14 years), who underwent two health checks by the Korea National Health Insurance Cooperative Organization
diagnosis
During an average follow-up of 7.
It can be seen that in large-scale Asian populations, dynamic changes in MetS status and persistent MetS are associated with increased risk of AF
In large-scale Asian populations, dynamic changes in MetS status and persistent MetS are associated with increased risk of AF
Original source:
Seo‐Young Lee.